XBiotech Inc. (XBIT) annual balance sheet — 14-year assets, liabilities & equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 |
|---|
| Total Current Assets | 117.05M | 126.95M | 174.57M | 201.72M | 219.84M | 246.87M | 325.88M | 716.26M | 17.02M | 33.33M | 36.93M | 93.04M | 58.06M | 7.69M | 4.36M |
| Cash & Short-Term Investments | 115.46M | 125.55M | 172.68M | 200.02M | 217.48M | 236.98M | 237.37M | 714.59M | 15.82M | 31.77M | 34.32M | 91.05M | 57.33M | 7.24M | 4.17M |
| Cash Only | 115.46M | 125.55M | 172.68M | 200.02M | 157.31M | 236.98M | 237.37M | 714.59M | 15.82M | 31.77M | 34.32M | 91.05M | 57.33M | 7.24M | 4.17M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 60.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 302K | 360K | 858K | 935K | 1.76M | 8.95M | 4.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | 160.56 | 177.66 | 34.12 | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.29M | 1.04M | 1.03M | 760K | 601K | 0 | 83.81M | 1.67M | 1.19M | 1.56M | 2.61M | 0 | 324K | 0 | 0 |
| Total Non-Current Assets | 22.79M | 23.13M | 24.53M | 24.9M | 26.26M | 28.31M | 27.87M | 100.61M | 27.33M | 29.64M | 30.12M | 16.32M | 4.11M | 3.38M | 4.11M |
| Property, Plant & Equipment | 22.79M | 23.13M | 24.53M | 24.9M | 26.26M | 28.31M | 27.34M | 25.17M | 27.33M | 29.64M | 30.12M | 16.32M | 4.11M | 3.38M | 4.11M |
| Fixed Asset Turnover | 0.00x | - | - | - | 0.15x | 0.65x | 1.61x | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 75M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | -1.66M | -1.09M | 0 | 75M | 0 | 0 | 0 | 0 | 0 | 0 | -4.11M |
| Total Assets | 139.84M | 150.08M | 199.09M | 226.62M | 246.1M | 275.18M | 353.74M | 816.88M | 44.34M | 62.97M | 67.05M | 109.36M | 62.18M | 11.07M | 8.47M |
| Asset Turnover | 0.00x | - | - | - | 0.02x | 0.07x | 0.12x | - | - | - | - | - | - | - | - |
| Asset Growth % | -82.67% | -24.62% | -12.14% | -7.92% | -10.57% | -22.21% | -56.7% | 1742.09% | -29.58% | -6.08% | -38.69% | 75.88% | 461.52% | 30.75% | - |
| Total Current Liabilities | 3M | 7.93M | 15.11M | 6.1M | 4.07M | 3.45M | 3.98M | 60.19M | 2.94M | 2.79M | 7.96M | 6.29M | 3.15M | 845K | 1.07M |
| Accounts Payable | 857K | 1.53M | 2.22M | 2.52M | 2.41M | 2.07M | 2.49M | 2.15M | 1.65M | 1.73M | 4.43M | 4.83M | 1.63M | 561K | 457K |
| Days Payables Outstanding | 1.34K | 332.31 | - | - | 1.35K | 129.76 | 26.32 | 332.23 | 247.98 | 425.51 | 2.32K | 2.52K | - | - | - |
| Short-Term Debt | 0 | 0 | 10.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.14M | 6.32M | 611K | 562K | 1.17M | 904K | 1.05M | 53.2M | 0 | 0 | 521K | 421K | 0 | 0 | 161K |
| Current Ratio | 39.03x | 16.01x | 11.56x | 33.07x | 54.07x | 71.49x | 81.80x | 11.90x | 5.78x | 11.94x | 4.64x | 14.79x | 18.45x | 9.10x | 4.09x |
| Quick Ratio | 39.03x | 16.01x | 11.56x | 33.07x | 54.07x | 71.49x | 81.80x | 11.90x | 5.78x | 11.94x | 4.64x | 14.79x | 18.45x | 9.10x | 4.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 1.82M | 1.8M | 1.72M | 1.67M | 1.64M | 2.34M | 1.12M | 1.06M | 3K | 18K | 23K | 17K | 0 | 0 | 30K |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K |
| Deferred Tax Liabilities | 10K | 5K | 0 | 0 | 59K | 873K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1.81M | 1.8M | 1.72M | 1.67M | 1.58M | 1.47M | 1.12M | 1.06M | 3K | 18K | 23K | 17K | 0 | 0 | 29K |
| Total Liabilities | 4.82M | 9.73M | 16.82M | 7.77M | 5.7M | 5.79M | 5.11M | 61.25M | 2.95M | 2.81M | 7.99M | 6.31M | 3.15M | 845K | 1.1M |
| Total Debt | 0 | 0 | 10.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K |
| Net Debt | -115.46M | -125.55M | -162.43M | -200.02M | -157.31M | -236.98M | -237.37M | -714.59M | -15.82M | -31.77M | -34.32M | -91.05M | -57.33M | -7.24M | -4.17M |
| Debt / Equity | 0.00x | - | 0.06x | - | - | - | - | - | - | - | - | - | - | - | 0.00x |
| Debt / EBITDA | -0.00x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | 2.47x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -632.78x | -46.79x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 135.02M | 140.35M | 182.27M | 218.85M | 240.4M | 269.38M | 348.64M | 755.63M | 41.4M | 60.16M | 59.06M | 103.05M | 59.03M | 10.23M | 7.37M |
| Equity Growth % | -70.77% | -23% | -16.71% | -8.97% | -10.76% | -22.73% | -53.86% | 1725.28% | -31.19% | 1.86% | -42.68% | 74.57% | 477.14% | 38.74% | - |
| Book Value per Share | 4.43 | 4.60 | 5.98 | 7.19 | 7.90 | 8.97 | 11.31 | 16.31 | 1.16 | 1.73 | 1.82 | 3.35 | 1.86 | 0.32 | 0.23 |
| Total Shareholders' Equity | 135.02M | 140.35M | 182.27M | 218.85M | 240.4M | 269.38M | 348.64M | 755.63M | 41.4M | 60.16M | 59.06M | 103.05M | 59.03M | 10.23M | 7.37M |
| Common Stock | 276.9M | 276.73M | 273.11M | 271.15M | 267.32M | 262.26M | 249.81M | 324.81M | 279.35M | 277.49M | 242.42M | 233.9M | 152.35M | 81.81M | 69.02M |
| Retained Earnings | -141.88M | -136.38M | -90.84M | -52.31M | -27.75M | 5.15M | 97.57M | 430.93M | -237.7M | -216.56M | -183.41M | -130.65M | -93.17M | -71.44M | -61.52M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 826K | 1.97M | 1.27M | -106K | -255K | -768K | 57K | -201K | -153K | -135K | -134K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying XBIT stock.
As of 2025, XBiotech Inc. (XBIT) had total assets of $150.1M including $127.0M in current assets.
XBiotech Inc. (XBIT) carries total debt of $0.0M, offset by $125.6M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
XBiotech Inc. (XBIT) has total shareholders' equity (book value) of $140.3M ($4.60 book value per share). Book value represents the net worth of the company belonging to common stock holders.
XBiotech Inc. (XBIT) reported a current ratio of 16.01x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.